Clinical trial for identifying the safety of the Ivermectin bath method. - The Ivermectin bath method

aboratory of medical safety management, Tokyo University of Science0 sites6 target enrollmentSeptember 27, 2012

Overview

Phase: 未知
Intervention: Not specified
Conditions: Not specified
Sponsor: aboratory of medical safety management, Tokyo University of Science
Enrollment: 6
Status: Completed
Last Updated: 2 years ago

No summary available.

Registry

who.int

Start Date

September 27, 2012

End Date

September 30, 2016

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

aboratory of medical safety management, Tokyo University of Science

•1\) Patient diagnosed with a skin disorder and thus has skin barrier problem 2\) One who has had the experience of the following; \- Hepatic disease \- The disease considered to affect the test results by doctor in attendance. \- The disease considered that use of Ivermectin results detrimental to the patient. 3\) one with excessive consumption of caffeine contained coffee or drink (\>8 cups / day) 4\) abuser of medication or alcohol 5\) The addict of an illegal drug 6\) One who has contributed 200mL blood within 4 weeks before the trial, or male contributed 400mL blood within 12 weeks and female contributed 400mL blood within 16 weeks 7\) One who participated in other clinical trials with the use of study medication within 4 weeks before the trial 8\) One who has an anamnesis of hypersensitivity for the ingredients contained in Stromectol Tablets or in the baby bath powder (Pigeon, Inc.) 9\) Pregnant female or lactating woman or child under 15kg weight 10\) One whom the doctor considered to be unsuitable for this clinical trial